Evidence map›Paper›PMID 23401654›Full record

ArticleMolecular vision2013

Further analysis of the lens of ephrin-A5-/- mice: development of postnatal defects.

Alexander I Son, Margaret A Cooper, Michal Sheleg, Yuhai Sun, Norman J Kleiman, Renping Zhou

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. International journal of molecular sciences · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.Investigative ophthalmology & visual science · 2014
    Article
  17. Article
  18. Article
  19. Epha2 and Efna5 participate in lens cell pattern-formation.Differentiation; research in biological diversity
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alexander I SonDepartment of Chemical Biology, Susan Lehman-Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Margaret A Cooper
Michal Sheleg
Yuhai Sun
Norman J Kleiman
Renping Zhou
Columbia University · USYale University · US

Funding

Regulation of Lens Fiber Cell OrganizationR01EY019012 · NEI · RUTGERS, THE STATE UNIV OF N.J. · PI ZHOU, RENPING · 2009 to 2013
$1.8M
ROLE OF EPHRIN-A5 IN LENS FIBER CELL ORGANIZATIONF31AG032806 · NIA · RUTGERS, THE STATE UNIV OF N.J. · PI SON, ALEXANDER INHA · 2008 to 2012
$122k
NEI NIH HHS R01 EY019012NEI NIH HHS R01EY019012NIA NIH HHS F31 AG032806NIA NIH HHS F31AG032806
6 · The paper itself

Abstract

purposeThe cells of the mammalian lens must be carefully organized and regulated to maintain clarity. Recent studies have identified the Eph receptor ligand ephrin-A5 as a major contributor to lens development, as mice lacking ephrin-A5 develop abnormal lenses, resulting in cataracts. As a follow-up to our previous study on the cataracts observed in ephrin-A5(-/-) animals, we have further examined the morphological and molecular changes in the ephrin-A5(-/-) lens.

methodsWild-type and ephrin-A5(-/-) eyes at various ages were fixed, sectioned, and examined using histological techniques. Protein expression and localization were determined using immunohistochemistry and western blot analysis.

resultsLens abnormalities in the ephrin-A5(-/-) animals are observed at postnatal stages, with lens opacity occurring by postnatal day 21. Structural defects in the lens are first observed in the outer lens fiber cell region where cells in the ephrin-A5(-/-) lens are severely disorganized. Ephrin-A5 and the Eph receptor EphA2 are expressed during early ocular development and continue to be expressed into postnatal stages. The cataracts in the ephrin-A5(-/-) mutants occur regardless of the presence of the CP49 mutation.

conclusionsIn this follow-up study, we have uncovered additional details explicating the mechanisms underlying ephrin-A5 function in the lens. Furthermore, elucidation of the expression of ephrin-A5 and the Eph receptor EphA2 in the lens supports a fundamental role for this receptor-ligand complex in lens development. These observations, in concert with our previous study, strongly suggest that ephrin-A5 has a critical role in postnatal lens fiber organization to maintain lens transparency.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCataractEphrin-A5Eye ProteinsIntermediate Filament ProteinsLens, CrystallineMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMice, TransgenicMutationReceptor, EphA2Severity of Illness IndexEphrin-A5Eye ProteinsIntermediate Filament ProteinsphakininReceptor, EphA2

Identifiers

PMID23401654
PMCPMC3566898
OpenAlexW1568461386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.